Welcome to our dedicated page for Chimera Invt news (Ticker: CIM), a resource for investors and traders seeking the latest updates and insights on Chimera Invt stock.
Chimera Investment Corporation (NYSE: CIM) is a mortgage-focused real estate investment trust whose news flow centers on mortgage credit, capital markets activity, and corporate developments. The company regularly issues press releases and related Form 8-K filings covering its financial results, dividends, securities offerings, and acquisitions.
Investors following CIM news will see quarterly earnings announcements that detail GAAP net income, earnings available for distribution, book value metrics, and the performance of its diversified portfolio of mortgage assets. These earnings releases are often accompanied by conference call and webcast details, as well as investor presentations posted on the company’s website and referenced in SEC filings.
Chimera also frequently reports on its dividend declarations for both common and preferred stock. Recent news includes board-approved quarterly cash dividends on common shares and multiple series of cumulative redeemable preferred stock, with corresponding Form 8-K filings describing the amounts, record dates, and payment dates.
Another key category of CIM news involves capital raising and balance sheet activity, such as the pricing and closing of public offerings of senior notes. These announcements outline coupon rates, maturities, listing symbols for the notes, and intended uses of proceeds, including financing the acquisition of residential mortgage loans, RMBS, CMBS, MSRs, and other targeted assets.
Corporate transaction updates, including the acquisition of HomeXpress Mortgage Corp. and related inducement equity awards under NYSE Rule 303A.08, are also prominent in Chimera’s news. For investors tracking mortgage REITs, CIM news provides ongoing insight into the company’s portfolio strategy, funding actions, and expansion of its mortgage lending and investment management platforms.
Bookmark this page to review a consolidated stream of Chimera Investment Corporation press releases, earnings updates, dividend announcements, capital markets transactions, and other material events as disclosed in company communications and SEC reports.
Chimera Investment (NYSE: CIM) has scheduled the release of its first quarter 2025 financial results for Thursday, May 8, 2025, before 7:00 a.m. EDT. The company will host a conference call and audio webcast to discuss the results at 8:30 a.m. EDT on the same day.
Chimera Investment operates as a publicly traded REIT focused on investing in diverse real estate assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, business purpose loans, MSRs, and other real estate-related assets such as Agency CMBS, junior liens, HELOCs, equity appreciation rights, and reverse mortgages.
Chimera Investment (NYSE: CIM) has sponsored two residential mortgage loan securitizations totaling $646 million on March 25, 2025. The first securitization, CIM 2025-R1, amounts to $391.8 million with loans having a 5.74% weighted average coupon, 636 FICO scores, and 50.80% LTV ratio. The second, CIM 2025-NR1, totals $254.4 million with a 5.67% weighted average coupon, 597 FICO scores, and 61.61% LTV ratio.
The company sold $333 million in senior securities for CIM 2025-R1 and $184.5 million for CIM 2025-NR1 to institutional investors, representing 85% and 72.50% of their respective capital structures. The net proceeds from both transactions exceeded $187 million. Palisades Advisory Services, Chimera's subsidiary, will serve as Asset Manager for both securitizations.
Chimera Investment (CIM) has announced its first quarter 2025 dividend distribution. The company's Board of Directors declared a cash dividend of $0.37 per common share. The dividend will be paid on April 30, 2025 to shareholders of record as of March 31, 2025, with the ex-dividend date set for March 31, 2025.
Chimera Investment (NYSE:CIM) reported its Q4 and full-year 2024 financial results. The company recorded a Q4 GAAP net loss of $2.04 per diluted share, while earnings available for distribution were $0.37 per diluted share. For the full year 2024, CIM achieved GAAP net income of $90 million ($1.10 per diluted share) and earnings available for distribution of $121 million ($1.48 per diluted share).
The company's GAAP book value stood at $19.72 per common share as of December 31, 2024, with an economic return of 4.40% for the year. The company made progress on building a more diversified portfolio and completed the Palisades acquisition, which is expected to strengthen their business and create additional shareholder value in 2025.
Total assets reached $13.12 billion, with loans held for investment representing the largest portion at $11.20 billion. The portfolio composition showed 87.6% in loans held for investment, 8.3% in Non-Agency RMBS, and 4.1% in Agency MBS and CMBS at fair value.
Chimera Investment (NYSE:CIM) reported its Q4 and full-year 2024 financial results. The company posted a Q4 GAAP net loss of $2.07 per diluted share, while achieving earnings available for distribution of $0.37 per share. For the full year 2024, CIM recorded GAAP net income of $90 million ($1.10 per diluted share) and earnings available for distribution of $121 million ($1.48 per diluted share).
The company's GAAP book value stood at $19.72 per common share as of December 31, 2024, with an economic return of 4.40% for the year. The company made progress on building a more diversified portfolio, with the Palisades acquisition expected to strengthen their business and create additional shareholder value in 2025 and beyond.
Chimera has declared its first quarter 2025 preferred stock dividends for all four series of its preferred shares. The dividends include:
- Series A (8.00%): $0.50 per share
- Series B (8.00% Fixed-to-Floating): $0.6488 per share, reflecting a 10.38139% rate
- Series C (7.75%): $0.484375 per share
- Series D (8.00% Fixed-to-Floating): $0.6231 per share, reflecting a 9.96939% rate
All dividends will be payable on March 31, 2025, to shareholders of record on March 3, 2025, with an ex-dividend date of March 3, 2025. The floating rates for Series B and D are based on three-month CME Term SOFR plus respective spreads.